(4a–4i) synthesized through a multi-component approach showed anticancer potency via in vitro cytotoxicity screening. Further, to develop the efficiency, derivatives (5a–5m) were synthesized and evaluated for their anti-proliferation activity. The most potent compound 5m showed cytotoxic effect toward SJSA-1 cells (IC50 = 3.14 μM) as well as inhibiting the growth of other cancer cell lines (HCT-116
通过多组分方法合成的一系列取代的3-
氨基-3-羟基甲基羟
吲哚(4a–4i)通过体外细胞毒性筛选显示了抗癌效力。此外,为了提高效率,合成了衍
生物(5a-5m)并评估了其抗增殖活性。最有效的化合物5m对SJSA-1细胞(IC 50 = 3.14μM)表现出细胞毒性作用,并抑制其他癌
细胞系(HCT-116,Jurkat,KB和Bel7402)的生长。进一步的研究表明,5m诱导SJSA-1细胞中显着的G2 / M细胞周期停滞以及时间和剂量依赖性细胞凋亡。这些结果表明,新化合物5m 具有抗增殖和促凋亡作用,这可能是癌症治疗的候选药物。